Cargando…
Metabolic Alterations in Pancreatic Cancer Progression
Pancreatic cancer is the third leading cause of cancer-related deaths in the USA. Pancreatic tumors are characterized by enhanced glycolytic metabolism promoted by a hypoxic tumor microenvironment and a resultant acidic milieu. The metabolic reprogramming allows cancer cells to survive hostile micro...
Autores principales: | Vernucci, Enza, Abrego, Jaime, Gunda, Venugopal, Shukla, Surendra K., Dasgupta, Aneesha, Rai, Vikrant, Chaika, Nina, Buettner, Kyla, Illies, Alysha, Yu, Fang, Lazenby, Audrey J., Swanson, Benjamin J., Singh, Pankaj K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016676/ https://www.ncbi.nlm.nih.gov/pubmed/31861288 http://dx.doi.org/10.3390/cancers12010002 |
Ejemplares similares
-
CD73 Induces GM-CSF/MDSC-mediated Suppression of T cells to Accelerate Pancreatic Cancer Pathogenesis
por: King, Ryan J., et al.
Publicado: (2022) -
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
por: Shukla, Surendra K., et al.
Publicado: (2015) -
MUC16-mediated activation of mTOR and c-MYC reprograms pancreatic cancer metabolism
por: Shukla, Surendra K., et al.
Publicado: (2015) -
Glucose Limitation
Alters Glutamine Metabolism in
MUC1-Overexpressing Pancreatic Cancer Cells
por: Gebregiworgis, Teklab, et al.
Publicado: (2017) -
SIRT1–NOX4 signaling axis regulates cancer cachexia
por: Dasgupta, Aneesha, et al.
Publicado: (2020)